原发性肝癌经肝动脉化疗栓塞术后发热的观察与护理  

Observation and nursing of fever in patients with primary liver cancer after transcatheter arterial chemoembolization

作　　者：高红霞[1] 纪雪莲[1] 葛冬云[1] 

机构地区：[1]中国医学科学院中国协和医科大学肿瘤医院,北京100021

出　　处：《齐鲁护理杂志》2003年第7期492-493,共2页Journal of Qilu Nursing

摘　　要：目的 :分析经肝动脉灌注化疗栓塞术 (TACE)治疗原发性肝癌后发热的原因及护理对策。方法 :将原发性肝癌患者 388例 ,根据所选治疗方法分为单纯灌注组 192例 ,灌注 +栓塞组 196例。对两组患者的体温进行观察。结果 :全部患者介入治疗后有 4 2 78%的患者出现发热 ,其中单纯灌注组发热率为18 75 % ,灌注 +栓塞组发热率为 6 6 33% (P <0 0 1)。灌注 +栓塞组碘化油用量 <10ml,发热率 36 4 % ,10～ 19ml发热率 5 5 2 0 % ,2 0～ 2 9ml发热率为88% ,>30ml发热率为 10 0 %。结论 :发热是TACE术后常见并发症之一 ,主要原因是术后肿瘤组织坏死吸收入血 ,发热发生率及发生程度与介入治疗方法及栓塞剂用量有关 。Objective:To discuss the mechanisms of fever and its management in patients with primary liver cancer(PLC) after transcatheter arterial chemoembolization(TACE) Method:388 patients with PLC,all diagnosed pathologically or clinically,were treated with TACE The patients were divided into two groups:those treated with intraarterial chemotherapy alone(192) and those treated with TACE (196) The body temperature was documented and analysed for this two groups of patients Result:42 78% of patients(166) developed fever after interventional therapy,18 75% of patients(36)treated with intraarterial chemotherapy alone developed fever,while as for the patients treated with TACE,66 33% of them(130)developed fever Conclusion:Fever is the one of the most common complications in patients with PLC treated with TACE It was considered to be due to necrosis of the tumor,infection,and chemotherapeutic agents,etc The management of the fever usually includes suitable use of febricides and antibiotics

关 键 词：原发性肝癌 经肝动脉化疗栓塞术 术后并发症 发热 临床观察 护理 

分 类 号：R735.7[医药卫生—肿瘤] R441.3[医药卫生—临床医学]